Biggest News Aggregation in the World
๐Ÿ“ฐ Thomas Equels News

Page 2 - Thomas Equels News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Thomas Equels. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

AIM ImmunoTech Inc.: AIM ImmunoTech Provides Summary of Ampligen Data Supporting Synergistic Potential with Checkpoint Blockade Therapies

Ampligen has demonstrated in pre-clinical and now human clinical studies a potential to enhance efficacy of PD-1 and/or PD-L1 checkpoint inhibitors Ampligen's anti-tumor potential is demonstrated with
United States Pawel Kalinski Jenene Thomas Michael Tony Hollingsworth Roswell Park Robert Edwards

AIM ImmunoTech Provides Summary of Ampligen Data Supporting Synergistic Potential with Checkpoint Blockade Therapies

21.04.2022 - Ampligen has demonstrated in pre-clinical and now human clinical studies a potential to enhance efficacy of PD-1 and/or PD-L1 checkpoint inhibitors Ampligenโ€™s anti-tumor potential is demonstrated with checkpoint blockade therapies in human clinical ... Seite 1
United States Thomas Equels Immunotech Inc Chief Executive Officer

NA Proactive news snapshot: Recruiter.com Group, Inc, Montero Mining and Exploration Ltd, Zeb Nickel Corp, Australis Capital Inc, Nomad Royalty Company Ltd, Fobi AI Inc, Revive Therapeutics Ltd, ESE Entertainment Inc., NorthWest Copper Corp...

Australis Capital Inc (CSE:AUSA, OTCQB:AUSAF), the cannabis company doing business as Audacious, gave shareholders an update on its commercial operations in...
Marudi Mountain Upper Takutu Essequibo United States United Kingdom British Columbia Toucan Creek

AIM ImmunoTech : Provides Progress on Advancement of Ampligen® Clinical Development Program for the Treatment of Pancreatic Cancer - Form 8-K

AIM ImmunoTech Inc. , an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19,... | April 12, 2022
United States Rintatolimod Ampligen Jenene Thomas Thomas Equels Immunotech Inc University Of Nebraska Medical Center

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science